AAAAAA

   
Results: 1-8 |
Results: 8
Botulinum toxin type A in, treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial
Authors: Naumann, M Lowe, NJ
Citation: M. Naumann et Nj. Lowe, Botulinum toxin type A in, treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial, BR MED J, 323(7313), 2001, pp. 596-599
Hyaluronic acid skin fillers: Adverse reactions and skin testing
Authors: Lowe, NJ Maxwell, CA Lowe, P Duick, MG Shah, K
Citation: Nj. Lowe et al., Hyaluronic acid skin fillers: Adverse reactions and skin testing, J AM ACAD D, 45(6), 2001, pp. 930-933
A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrantnodular acne
Authors: Strauss, JS Leyden, JJ Lucky, AW Lookingbill, DP Drake, LA Hanifin, JM Lowe, NJ Jones, TM Stewart, DM Jarratt, MT Katz, I Pariser, DM Pariser, RJ Tschen, E Chalker, DK Rafal, ES Savin, RP Roth, HL Chang, LK Baginski, DJ Kempers, S McLane, J Eberhardt, D Leach, EE Bryce, G Hong, J
Citation: Js. Strauss et al., A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrantnodular acne, J AM ACAD D, 45(2), 2001, pp. 187-195
Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin
Authors: Strauss, JS Leyden, JJ Lucky, AW Lookingbill, DP Drake, LA Hanifin, JM Lowe, NJ Jones, TM Stewart, DM Jarratt, MT Katz, I Pariser, DM Pariser, RJ Tschen, E Chalker, DK Rafal, ES Savin, RP Roth, HL Chang, LK Baginski, DJ Kempers, S McLane, J Hong, J Leach, EE Bryce, G Eberhardt, D
Citation: Js. Strauss et al., Safety of a new micronized formulation of isotretinoin in patients with severe recalcitrant nodular acne: A randomized trial comparing micronized isotretinoin with standard isotretinoin, J AM ACAD D, 45(2), 2001, pp. 196-207
Tazarotene plus UVB phototherapy in the treatment of psoriasis
Authors: Koo, JYM Lowe, NJ Lew-Kaya, DA Vasilopoulos, AI Lue, JC Sefton, J Gibson, JR
Citation: Jym. Koo et al., Tazarotene plus UVB phototherapy in the treatment of psoriasis, J AM ACAD D, 43(5), 2000, pp. 821-828
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Authors: Abrams, JR Lebwohl, MG Guzzo, CA Jegasothy, BV Goldfarb, MT Goffe, BS Menter, A Lowe, NJ Krueger, G Brown, MJ Weiner, RS Birkhofer, MJ Warner, GL Berry, KK Linsley, PS Krueger, JG Ochs, HD Kelley, SL Kang, SW
Citation: Jr. Abrams et al., CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris, J CLIN INV, 103(9), 1999, pp. 1243-1252
Optimizing therapy: tazarotene in combination with phototherapy
Authors: Lowe, NJ
Citation: Nj. Lowe, Optimizing therapy: tazarotene in combination with phototherapy, BR J DERM, 140, 1999, pp. 8-11
Scar revision using laser - review of the literature and an appraisal
Authors: Sawcer, D Lee, HR Lowe, NJ
Citation: D. Sawcer et al., Scar revision using laser - review of the literature and an appraisal, J DERM TR, 9(4), 1998, pp. 251-257
Risultati: 1-8 |